Take Control of Your Health Care Spend
Self-Funded employers partnering with Regenexx’s Interventional Orthopedics strategy are reducing their orthopedic spend by up to 70%* and offering their employees a choice in care that they choose more than 95% of the time.
More than 93,050 Regenexx® Procedures have been performed since Regenexx pioneered orthopedic stem cell treatments in 2005. Regenexx Procedures are the most advanced orthopedic stem cell procedures in the world.
The published research on Regenexx procedures accounts for approx. 44% of the world’s orthopedic stem cell literature (cumulative n of patients published & treated with bone marrow stem cells as of 1/1/2019)
Savings from the Surgical Alternative*
Patient Improvement at 6 months
Why Self Insured Employers are Turning to Regenexx
Listen to representatives from Meredith Corporation explain why they chose to cover procedures at Regenexx for their employees.
Regenexx procedures are the next generation of orthopedic recovery that provide an alternative to surgery with superior outcomes. We offer the most advanced stem-cell treatment available in the United States supported by an extensive outcomes database.
“Edison Healthcare welcomes Regenexx to the team. They offer a low cost and safe way to treat certain orthopedic problems. We expect employers and their employees to see great value in this program.”
CEO and Co-founder of Edison Healthcare
“Our job is to help employers across the US implement ways to gain control of their benefits spend and reduce that massive line item, while simultaneously increasing productivity. Because musculoskeletal spend is generally one of the largest claims classes for an insured population, introducing Regenexx into these plans immediately allows for significant savings, and yet equally important, provides superior outcomes for the lives they touch.”
CEO of Connect Healthcare Collaboration
“Our goal is to offer innovative, cutting edge and robust programs and resources for our employee’s that tie into our health and well-being strategy. We believe in offering choice to our employees to help them avoid invasive surgery and the resulting long recovery allowing them to get back to their lives more quickly. We think that adding the Regenexx Procedures is a valuable addition to our program that is helping us accomplish our goals”
Director of Employee Benefits and Wellness Meredith Corporation
“When given the equal choice our corporate partner employees are choosing the Regenexx Procedures 99.6% of the time over the surgical alternative. It is crystal clear that employees want this alternative.”
“To allow employees to choose not to have surgery and to recover very quickly with much lower cost but also much lower absenteeism and a lot less pain and suffering.”
Chairman and CEO Meredith Corporation
“When it comes to solving America’s healthcare crisis, employers are the answer. With Regenexx, ACAP Health gains a partner dedicated to treating musculoskeletal injury, which is typically the leading diagnosis area for employer health plans in terms of total spend.”
CEO of ACAP Health
“As an insurance executive for over 25 years I’ve seen the statistics of complications due to elective surgery which include death, heart attack and stroke. In leading Regenexx and understanding the benefits of Regenexx procedures, once an employer knows they can add these benefits to their plan, I believe they are obligated to give their employees this choice in orthopedic healthcare. It’s a solution with zero downside.”
United States Regenexx Provider Network
Regenexx has a rapidly growing provider map, comprised of doctors who are musculoskeletal specialists trained by Regenexx. Call us at 877-341-5968 for details on how the Regenexx Corporate Orthopedic Benefits Plan can help you.
Regenexx® Patient Success Stories
* This data was calculated based on the gross savings realized from substituting percutaneous orthobiologic procedures for invasive, elective orthopedic surgeries within our pilot program in Des Moines, IA. Now that we have more data from more clients, we will update our cost savings on a quarterly basis using a sampling methodology, later this year we will be introducing an actuarial based process.